Results 191 to 200 of about 681,792 (231)

Urothelial Carcinoma: The Development of FGFR Inhibitors in Combination With Immune Checkpoint Inhibitors

Expert Review of Anticancer Therapy, 2020
Matthew D Galsky, Qian Qin, Vaibhav G Patel   +2 more
exaly  

Acquired resistance to selective FGFR inhibitors in FGFR-altered cholangiocarcinoma

European Journal of Cancer, 2020
L. Goyal, I. Baiev, K. Zhang, S. Dalgai, R.T. Shroff, R.K. Kelley, N. Uboha   +6 more
openaire   +1 more source

PTERIDINES AS FGFR INHIBITORS

2013
SAXTY GORDON, HAMLETT CHRISTOPHER CHARLES FREDERICK, BERDINI VALERIO, MURRAY CHRISTOPHER WILLIAM, ANGIBAUD PATRICK RENÉ, QUEROLLE OLIVIER ALEXIS GEORGES, PONCELET VIRGINIE SOPHIE   +6 more
openaire   +5 more sources

Discovery of 4,6-Pyrimidinediamine Derivatives as Novel Dual EGFR/FGFR Inhibitors Aimed EGFR/FGFR1-Positive NSCLC

European Journal of Medicinal Chemistry, 2020
Xuebao Wang, Bo Chen, Zixin Xie
exaly  

Prevention and Treatment of FGFR Inhibitor-Associated Toxicities

Critical Reviews in Oncology/Hematology, 2020
James Yu, Amit Mahipal, Richard D Kim
exaly  

FGFR EXPRESSION AND SUSCEPTIBILITY TO AN FGFR INHIBITOR

2017
VASLIN-CHESSEX ANNE, MOULON CORINNE, BRICHORY FRANCK, POKORSKA-BOCCI ANNA   +3 more
openaire   +3 more sources

Salts of an FGFR inhibitor

2021
JIA ZHONGJIANG, ZHOU JIACHENG, LI QUN
openaire   +2 more sources

COMBINATIONS OF AN FGFR INHIBITOR AND AN IGF1R INHIBITOR

2015
JOVCHEVA ELEONORA, PERERA TIMOTHY PIETRO SUREN   +1 more
openaire   +3 more sources

FGFR INHIBITORS FOR THE TREATMENT OF CANCER

2020
CAO PING, ZHANG CHAO, BISHOP MICHAEL J
openaire   +3 more sources

Fused Pyrazoles as FGFR Inhibitors

2014
ZHUO JINCONG, XU MEIZHONG, QIAN DING-QUAN   +2 more
openaire   +2 more sources